Correlation Between Sk Biopharmaceutica and SM Entertainment

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sk Biopharmaceutica and SM Entertainment at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sk Biopharmaceutica and SM Entertainment into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sk Biopharmaceuticals Co and SM Entertainment Co, you can compare the effects of market volatilities on Sk Biopharmaceutica and SM Entertainment and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sk Biopharmaceutica with a short position of SM Entertainment. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sk Biopharmaceutica and SM Entertainment.

Diversification Opportunities for Sk Biopharmaceutica and SM Entertainment

-0.13
  Correlation Coefficient

Good diversification

The 3 months correlation between 326030 and 041510 is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding Sk Biopharmaceuticals Co and SM Entertainment Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SM Entertainment and Sk Biopharmaceutica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sk Biopharmaceuticals Co are associated (or correlated) with SM Entertainment. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SM Entertainment has no effect on the direction of Sk Biopharmaceutica i.e., Sk Biopharmaceutica and SM Entertainment go up and down completely randomly.

Pair Corralation between Sk Biopharmaceutica and SM Entertainment

Assuming the 90 days trading horizon Sk Biopharmaceutica is expected to generate 1.2 times less return on investment than SM Entertainment. But when comparing it to its historical volatility, Sk Biopharmaceuticals Co is 1.18 times less risky than SM Entertainment. It trades about 0.04 of its potential returns per unit of risk. SM Entertainment Co is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  7,360,000  in SM Entertainment Co on September 1, 2024 and sell it today you would earn a total of  1,120,000  from holding SM Entertainment Co or generate 15.22% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy99.45%
ValuesDaily Returns

Sk Biopharmaceuticals Co  vs.  SM Entertainment Co

 Performance 
       Timeline  
Sk Biopharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sk Biopharmaceuticals Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
SM Entertainment 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in SM Entertainment Co are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, SM Entertainment sustained solid returns over the last few months and may actually be approaching a breakup point.

Sk Biopharmaceutica and SM Entertainment Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sk Biopharmaceutica and SM Entertainment

The main advantage of trading using opposite Sk Biopharmaceutica and SM Entertainment positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sk Biopharmaceutica position performs unexpectedly, SM Entertainment can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SM Entertainment will offset losses from the drop in SM Entertainment's long position.
The idea behind Sk Biopharmaceuticals Co and SM Entertainment Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated